Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
53,748
+26,028
+94% +$567K 0.02% 1376
2026
Q1
$481K Buy
+27,720
New +$525K 0.01% 2088
2025
Q2
Sell
-22,949
Closed -$407K 2427
2025
Q1
$407K Sell
22,949
-8,184
-26% -$176K 0.02% 1179
2024
Q4
$667K Buy
31,133
+15,214
+96% +$370K 0.05% 532
2024
Q3
$497K Buy
+15,919
New +$396K 0.04% 823
2024
Q2
Sell
-21,264
Closed -$225K 1924
2024
Q1
$225K Buy
+21,264
New +$213K 0.03% 1079
2023
Q4
Sell
-21,201
Closed -$148K 1647
2023
Q3
$148K Sell
21,201
-14,874
-41% -$137K 0.03% 1107
2023
Q2
$307K Buy
36,075
+17,098
+90% +$143K 0.06% 702
2023
Q1
$173K Buy
+18,977
New +$243K 0.04% 995
2022
Q4
Sell
-10,556
Closed -$180K 1156
2022
Q3
$180K Buy
+10,556
New +$227K 0.04% 817
2021
Q4
Sell
-3,874
Closed -$245K 712
2021
Q3
$245K Buy
+3,874
New +$295K 0.08% 417

Other funds holding CDNA

XTX Topco's CDNA Position: Q2 2026 in Review

XTX Topco increased its CareDx (CDNA) stake by 94% in Q2 2026, buying an estimated $567K and bringing the position to 53,748 shares worth $1.53M. The position accounts for 0.02% of the portfolio, ranked #1376.

XTX Topco first reported a position in CDNA in Q3 2021 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • XTX Topco held 53,748 shares of CareDx worth $1.53M as of Q2 2026.
  • XTX Topco bought 26,028 CareDx shares in Q2 2026, an estimated $567K.
  • CareDx made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1376 holding.
  • XTX Topco first reported a position in CareDx in Q3 2021 and has held it in 11 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.